Provided by Tiger Fintech (Singapore) Pte. Ltd.

Iterum Therapeutics Plc

1.09
-0.0350-3.12%
Volume:485.60K
Turnover:527.96K
Market Cap:37.52M
PE:-0.86
High:1.14
Open:1.14
Low:1.07
Close:1.12
Loading ...
Feb 05, 2021

Major Issues Report

8-K - Current report
Feb 04, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Feb 04, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Feb 03, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Major Issues Report

8-K - Current report
Jan 29, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 28, 2021

Major Issues Report

8-K - Current report
Dec 23, 2020

Major Issues Report

8-K - Current report
Dec 21, 2020

Major Issues Report

8-K - Current report
Dec 02, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 23, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Nov 16, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 16, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 02, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 29, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Oct 27, 2020

Major Issues Report

8-K - Current report
Oct 22, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 21, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 20, 2020

Correspondence

CORRESP [Cover] - Correspondence